{
    "Trade/Device Name(s)": [
        "Oral Fluid Amphetamine Assay",
        "DAT Oral Fluid Amphetamine Assay",
        "Oral Fluid DAT Qual Cal B",
        "Oral Fluid DAT SQ Cal B",
        "Oral Fluid DAT Control Set B"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K110446",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992918"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "February 15, 2011",
    "Summary Letter Received Date": "February 16, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine"
    ],
    "Specimen Type(s)": [
        "Oral Fluid"
    ],
    "Specimen Container(s)": [
        "Intercept Oral Specimen Collection Device"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Kinetic interaction of microparticles in solution (KIMS)",
        "Enzyme Immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche DAT Oral Fluid Amphetamine Assay and related calibrators/controls using KIMS technology for qualitative and semi-quantitative detection of amphetamine in oral fluid.",
    "Indications for Use Summary": "In vitro diagnostic for qualitative and semi-quantitative detection of amphetamine in human oral fluid collected exclusively with the Intercept Oral Specimen Collection Device; results aid labs in assessing assay performance and estimating dilutions for confirmation by LC/MS/MS.",
    "fda_folder": "Toxicology"
}